Skip to Content

G220 150 (Lithium Carbonate 150 mg)

Pill with imprint G220 150 is White, Capsule-shape and has been identified as Lithium Carbonate 150 mg. It is supplied by Glenmark Generics Inc..

Lithium is used in the treatment of bipolar disorder; mania; schizoaffective disorder and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G220 150

Lithium carbonate 150 mg G220 150

Lithium Carbonate

Imprint
G220 150
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Generics Inc.
National Drug Code (NDC)
68462-0220
Inactive Ingredients
FD&C Red No. 40, sodium lauryl sulfate, magnesium silicate, titanium dioxide, ferrosoferric oxide, shellac, FD&C Blue No. 1, D&C Yellow No. 10, silicon dioxide, propylene glycol, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.